Organisation paid for research Program year 2024 Source: CMS Open Payments

UPMC General Surgery

Neither a doctor nor a teaching hospital

Research payments

$216,968

66 payments

Through program year 2024, UPMC General Surgery is reported as receiving $216,968 in research payments, across 66 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$1,022	2
2021	Research	$26,052	2
2020	Research	$189,894	62

Breakdown

Who paid Research payments · program years 2020–2024

GlaxoSmithKline, LLC. $110,048 53 payments
Takeda Pharmaceuticals U.S.A., Inc. $105,898 11 payments
Globus Medical, Inc. $1,022 2 payments

Studies the money was for Research payments · program years 2020–2024

Menb Rec 2Nd Gen-023 (V72_57) $110,048 53 payments
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study to Assess the Efficacy and Safety of Shp620 Compared to Standard of Care for the Treatment of Cytomegalovirus (CMV) Infections That Are Resistant Or Refractory to Treatment With Ganciclovir, Valganciclovir, Foscarnet, Or Cidofovir in Transplant Recipients $79,846 9 payments
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study to Assess the Efficacy and Safety of Shp620 Compared to Standard of Care for the Treatment of Cytomegalovirus (CMV) Infections That Are Resistant Or Refractory to Treatment With Ganciclovir, Valganciclovir, Foscarnet, Or Cidofovir in Transplant Recipients $26,052 2 payments
A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine $1,022 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.